錫業股份(000960.SZ):以9.77億元成功競得華聯鋅銦8.37%股份
格隆匯8月1日丨錫業股份(000960.SZ)公佈,2022年7月29日,錫業股份收到北金所出具的《交易結果通知書》,錫業股份以9.772億元成功競得華聯鋅銦8.37%股份(對應華聯鋅銦【2591.1431】萬元註冊資本)。同日,公司與本次交易出讓方建信金融資產投資有限公司(簡稱“建信投資”)(代表:【建信投資-華聯鋅銦債轉股投資計劃】)簽訂《雲南華聯鋅銦股份有限公司股權轉讓協議》。8月1日,公司根據《協議》有關約定向建信投資支付華聯鋅銦8.37%股份轉讓價款9.772億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.